Bioptigen Inc. is an ISO 13485-certified medical device company that develops innovative ophthalmic imaging solutions. Bioptigen’s Envisu(tm) R-class systems are ideally suited to non-invasive ophthalmic imaging of animals ranging from zebrafish to elephants. Using low-power, near-infrared light, Envisu generates real-time, high-resolution, volumetric images of ocular microstructures from the cornea to the retina. Bioptigen has received CE approval to market its hand-held Envisu R2000 systems for preclinical use and C2000 systems for clinical use within the EU.
Looking for a particular Bioptigen, Inc. employee's phone or email?
The Bioptigen, Inc. annual revenue was $6.1 million in 2026.
Frank Choe is the Director of Operations of Bioptigen, Inc..
2 people are employed at Bioptigen, Inc..
Bioptigen, Inc. is based in Morrisville, North Carolina.
The NAICS codes for Bioptigen, Inc. are [33, 339, 45].
The SIC codes for Bioptigen, Inc. are [59, 599].